1. Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
   Caichen Li et al, 2020, Front. Oncol. CrossRef
2. Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
   Yassine Belloum et al, 2020, Cells CrossRef
3. Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review
   Jasmina Obradovic et al, 2021, Mol Biol Rep CrossRef
4. Early On-Treatment Prediction of the Mechanisms of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
   Yu-ra Choi et al, 2022, Cancers CrossRef
5. PCR Techniques and Their Clinical Applications
   Mingke Wang et al, 2023 CrossRef
6. Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements
   Grégoire Cullot et al, 2023, The CRISPR Journal CrossRef
7. Plasma Exosome Analysis for Protein Mutation Identification Using a Combination of Raman Spectroscopy and Deep Learning
   Seungmin Kim et al, 2023, ACS Sens. CrossRef
8. Custom-Designed Probes for the Accurate Determination of Epidermal Growth Factor Receptor Mutations and Their Allelic Configuration
   Jiaqi Li et al, 2024, Anal. Chem. CrossRef
9. The most common methods applied for in vitro research in non-small cell lung cancer in the last decade
   Jovana Todosijević-Jovanović et al, 2024, Acta fac medic Naissensis CrossRef